insights_auto
Nega CMXHF oshdi 2,22%?
Batafsil oʻrganishchevron_right
CMXHF:OTCMKTS
CSL Ltd
123,79 US$
arrow_upward
+2,22%(+2,69) 1K
15-okt, 16:00:00 (GMT-4) · USD
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoCMXHF tikeri uchun statistika yaratilmoqda...
Ochish
129,22 US$
Yuqori
129,22 US$
Past
123,79 US$
Bozor kapitali
92,23 mlrd
Oʻrtacha hajm
167,00
Hajmi
564,00
52 haftalik eng yuqori
148,36 US$
52 haftalik eng past
63,84 US$
Beta
0,56
Muomaladagi aksiyalar
479,88 mln
Xodimlar soni
29 ming
Ochish
129,22 US$
Yuqori
129,22 US$
Past
123,79 US$
Bozor kapitali
92,23 mlrd
Oʻrtacha hajm
167,00
Hajmi
564,00
52 haftalik eng yuqori
148,36 US$
52 haftalik eng past
63,84 US$
Beta
0,56
Muomaladagi aksiyalar
479,88 mln
Xodimlar soni
29 ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
TheBull.com.au
·
1 kun oldin
CSL Shares Double Off Lows: How Do They Stack Up Against TLX, SIG?
ad-hoc-news.de
·
1 kun oldin
CSL agrees Alentis drug deal as CSL stock has AUD 89.7 billion value
Profil
CSL Limited is an Australian multinational specialty biotechnology company that researches, develops, manufactures, and markets products to treat and prevent serious human medical conditions. CSL's product areas include blood plasma derivatives, vaccines, antivenom, and cell culture reagents used in various medical and genetic research and manufacturing applications. The company was established in 1916 as Commonwealth Serum Laboratories and was wholly owned by the Australian federal government until its privatisation in 1994. Wikipedia
CSL Ltd haqida
CEOPaul McKenzie
Xodimlar soni29 ming
Asos solingan1916
Bosh ofislarMelburn, Victoria, Avstraliya
Sektor-
Veb-saytcsl.com